Murali, A., Issa, Z. A., Freitas, C. M. D., Rajendra, A., Davidson, M., Bankar, A., Sibai, H., Perusini, M., Chan, S., Schimmer, A., Minden, M., Yee, K. W., Schuh, A., Gupta, V., Maze, D., Richard-Carpentier, G. (2025). Morphologic leukemia-free state (MLFS) is associated with inferior outcomes in patients with Acute Myeloid Leukemia (AML) treated with front-line azacitidine plus venetoclax. Blood. https://doi.org/10.1182/blood-2025-3508